Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey

被引:10
|
作者
Kaur, Sukhpal [1 ]
Singh, Ajay [2 ]
Saini, Sushma [1 ]
Rohilla, Latika [1 ]
Kaur, Jasvir [1 ]
Chandi, Anadeep [3 ]
Kaur, Gurpreet [1 ]
Singh, Manjeet [9 ]
Kumar, Pramod [1 ]
Soni, Shiv Lal [10 ]
Kajal, Kamal [2 ]
Naik, Naveen B. [2 ]
Malhotra, Pankaj [4 ]
Verma, Sanjay [5 ]
Gupta, Madhu [6 ]
Devnani, Mahesh [7 ]
Das, Karobi [1 ]
Pandav, S. S. [8 ]
Puri, G. D. [2 ]
机构
[1] Govt Multispecial Hosp, Natl Inst Nursing Educ, Dept Nursing, Chandigarh, India
[2] Govt Multispecial Hosp, Dept Anaesthesia & Intens Care, Chandigarh, India
[3] Govt Multispecial Hosp, Dept Obstet & Gynaecol, Chandigarh, India
[4] Govt Multispecial Hosp, Dept Internal Med, Chandigarh, India
[5] Govt Multispecial Hosp, Dept Paediat, Chandigarh, India
[6] Govt Multispecial Hosp, Dept Community Med, Chandigarh, India
[7] Govt Multispecial Hosp, Hosp Adm, Chandigarh, India
[8] Multispecial Hosp, Postgrad Inst Med Educ & Res, Ophthalmol, Chandigarh, India
[9] Govt Multispecial Hosp, Dept Med, Chandigarh, India
[10] Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Sect 12, Chandigarh 160012, India
关键词
Adverse events; ChAdOx1; nCoV-19; coronavirus disease 2019; healthcare professionals; side effects; vaccination;
D O I
10.4103/ijmr.ijmr_1221_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: The safety of the ChAdOx1 nCoV-19 vaccine is a cause of concern for many who have been vaccinated. The people have multiple concerns and fear regarding the adverse events of the vaccine. Thus, this study was undertaken to establish the safety profile of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) among the healthcare professionals. Methods: This was a descriptive cross-sectional survey. After taking clearance from the institutional ethics committee 1500 healthcare professionals, who had their vaccination in the past two weeks were selected. They were provided with an online survey proforma regarding adverse events following immunization (AEFIs) of COVID-19 vaccine developed using google forms with an informed consent form affixed to it. Results: A total of 1036 individuals participated in the study. The mean and median (inter quartile range) age of the participants was 37.7 +/- 11.25 and 35 (29-46) yr, respectively. Of these, 52.1 per cent were female, 29.3 per cent were doctors, 33.4 per cent were nurses and 9.5 per cent were paramedical staff. Forty six per cent participants experienced one or more minor AEFIs such as pain, tenderness, redness, etc. at the injection site. Fatigue (31.75%), generalized feeling of unwell (28.57%), muscle pain (23.16%) and fever (21.71%) were the most commonly reported systemic AEFIs followed by headache (20.07%), dizziness (10.03%) and joint pains (15.25%). Most of them experienced these AEFIs within 24 h of the first dose of administration. About 42 per cent of the participants took oral antipyretics/analgesics for managing the AEFIs. Interpretation & conclusions: ChAdOx1 nCoV-19 Corona Virus Vaccine was found to be associated with mild local and systemic AEFIs that were more common after the first dose as compared to the second dose. There adverse events could be dealt with oral over-the-counter medications, with no requirement of hospitalization.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [21] Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
    Somy Cherian
    Aby Paul
    Sakir Ahmed
    Bazil Alias
    Manesh Manoj
    Ansu K. Santhosh
    Delcey Rachel Varghese
    Narayanan Krishnan
    Padmanabha Shenoy
    Rheumatology International, 2021, 41 : 1441 - 1445
  • [22] Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
    Cherian, Somy
    Paul, Aby
    Ahmed, Sakir
    Alias, Bazil
    Manoj, Manesh
    Santhosh, Ansu K.
    Varghese, Delcey Rachel
    Krishnan, Narayanan
    Shenoy, Padmanabha
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (08) : 1441 - 1445
  • [23] Serious adverse events following immunization after ChAdOx1 nCov-19 vaccination in India: a single center experience
    Maurya, Miteshkumar Rajaram
    Ravi, Renju
    Pushparajan, Libby
    PAN AFRICAN MEDICAL JOURNAL, 2021, 40
  • [24] A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy
    Palladino, Raffaele
    Ceriotti, Daniele
    De Ambrosi, Damiano
    De Vito, Marta
    Farsoni, Marco
    Seminara, Giuseppina
    Barone-Adesi, Francesco
    VACCINES, 2021, 9 (06)
  • [25] Presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies Among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine
    Vu, Dien M.
    Vu, Diep T. B.
    Do, Thuy T. T.
    Olmsted, Allison E.
    Dao, Bach H.
    Thai, Truc T.
    Nguyen, Chi L.
    Le, Nhung T. T.
    Le, Tuan A.
    Bui, Hien T. T.
    Pham, Thach N.
    Moore, Matthew R.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S174 - S181
  • [26] Serious events following COVID-19 vaccination with ChAdOx1 nCoV-19 vaccine (Vaxzevria) : A short case series from Iran
    Khajavirad, Nasim
    Salehi, Mohammadreza
    Ghadery, Abdolkarim Haji
    Khalili, Hossein
    Ahmadi, Mehran Arab
    Manshadi, Seyed Ali Dehghan
    Dehnavi, Ali Zare
    CLINICAL CASE REPORTS, 2022, 10 (02):
  • [27] Rates, types, and associated factors of acute adverse effects after the first dose of ChAdOx1 nCoV-19 vaccine administration in Thailand
    Watcharananan, Sirapat Arthur
    Nadee, Chalermlap
    Kongsuwattanaleart, Patis
    Sangthong, Nussara
    Ngorsakun, Punpen
    Vimonvattaravetee, Pornpimon
    Phuphuakrat, Angsana
    Udomsubpayakul, Umaporn
    IJID REGIONS, 2022, 2 : 35 - 39
  • [28] Post ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (Covishield) Brachial Plexitis - Report of Two Cases Along with Review of Literature
    Jain, Rajendra Singh
    Pandey, Garima
    Shah, Chandani J.
    Sukhani, Paresh
    Kabra, Utkarsh
    NEUROLOGY INDIA, 2024, 72 (06) : 1254 - 1258
  • [29] Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
    Havervall, Sebastian
    Marking, Ulrika
    Greilert-Norin, Nina
    Ng, Henry
    Gordon, Max
    Salomonsson, Ann-Christin
    Hellstrom, Cecilia
    Pin, Elisa
    Blom, Kim
    Mangsbo, Sara
    Phillipson, Mia
    Klingstrom, Jonas
    Hober, Sophia
    Nilsson, Peter
    Aberg, Mikael
    Thalin, Charlotte
    EBIOMEDICINE, 2021, 70
  • [30] Platelet Activation and Cytokine Release of Interleukin-8 and Interferon-Gamma-Induced Protein 10 after ChAdOx1 nCoV-19 Coronavirus Vaccine Injection
    Shen, Chih-Lung
    Wang, Tso-Fu
    Liu, Chao-Zong
    Wu, Yi-Feng
    VACCINES, 2023, 11 (02)